VC
CELG

V2 Capital’s Celgene Corp CELG Stock Holding History

V2 Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$1.31M Buy
+11,367
New +$1.36M 0.54% 47

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

V2 Capital's CELG Position: Q1 2015 in Review

V2 Capital opened a new position in Celgene Corp (CELG) in Q1 2015: 11,367 shares worth $1.31M. The stake represents 0.54% of the portfolio and ranks #47 among its holdings.

1,193 funds tracked by Wall St. Rank hold CELG as of Q1 2015.

  • V2 Capital held 11,367 shares of Celgene Corp worth $1.31M as of Q1 2015.
  • Celgene Corp was a new V2 Capital position in Q1 2015.
  • Celgene Corp made up 0.54% of V2 Capital's portfolio in Q1 2015, its #47 holding.
  • 1,193 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2015.

Based on V2 Capital's 13F filing for Q1 2015, filed 5 May 2015.